PMV

Augustine Therapeutics N.V., founded in 2019 and based in Gent, Belgium, focuses on developing innovative medicines for patients suffering from Charcot-Marie-Tooth disease and other neuromuscular disorders. The company is engaged in two drug discovery programs aimed at identifying new generations of selective HDAC6 inhibitors, which are designed to address axonopathies, including Charcot-Marie-Tooth disease. These novel compounds are intended to protect against nerve degeneration and facilitate the repair of peripheral myelin and axons. By advancing these therapeutic drugs, Augustine Therapeutics aims to enhance the quality of life for patients affected by these debilitating conditions.

Minze Health is a Belgian healthtech startup founded in 2015 and headquartered in Antwerp. The company specializes in developing digital health solutions aimed at addressing urinary tract problems, particularly focusing on urologic, pelvic health, and continence care. Its platform facilitates the diagnostic and treatment processes, as well as remote patient monitoring for individuals suffering from lower urinary tract symptoms (LUTS). Minze Health's innovative solutions are utilized by hospitals, urology practices, and pelvic floor rehabilitation centers around the globe, enabling healthcare professionals to effectively diagnose and monitor their patients both in clinical settings and private practices.

Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company focuses on developing internal drug discovery programs centered on G-protein coupled receptors (GPCRs), which are critical targets for therapeutic intervention. Utilizing its proprietary CONFO technology, Confo Therapeutics stabilizes active-state conformations of GPCRs, enabling researchers to access previously unreachable structural features. This innovation facilitates the discovery of novel agonists, addressing unmet medical needs and potentially leading to improved treatments in the medical field. The company aims to build a robust portfolio of drug discovery programs, leveraging its unique approach to enhance therapeutic options.

Augustine Therapeutics N.V., founded in 2019 and based in Gent, Belgium, focuses on developing innovative medicines for patients suffering from Charcot-Marie-Tooth disease and other neuromuscular disorders. The company is engaged in two drug discovery programs aimed at identifying new generations of selective HDAC6 inhibitors, which are designed to address axonopathies, including Charcot-Marie-Tooth disease. These novel compounds are intended to protect against nerve degeneration and facilitate the repair of peripheral myelin and axons. By advancing these therapeutic drugs, Augustine Therapeutics aims to enhance the quality of life for patients affected by these debilitating conditions.

Gorilla focuses on transforming the energy and utility industry through innovative energy data applications. The company addresses longstanding data challenges that hinder innovation by offering a robust architectural data foundation tailored specifically for energy companies. Its platform features a flexible data model and a stable environment, which includes reusable algorithms that facilitate a quicker digital transformation process. By automating data collection and providing tools for pricing, forecasting, and reporting, Gorilla empowers energy retailers to leverage data-driven technology, thereby enhancing their sales while mitigating risks. With offices in Antwerp, London, Austin, and Melbourne, Gorilla is positioned to support energy companies in maximizing their return on investment from data.

MICLEDI Microdisplays BV specializes in designing and manufacturing micro light-emitting diode (microLED) display chips tailored for augmented reality (AR) glasses. Based in Leuven, Belgium, the company operates as a fabless developer, focusing on advanced technology that integrates III/V materials processing, 3D integration, and 300mm silicon-based processing. MICLEDI's proprietary application-specific integrated circuit (ASIC) enables the production of compact, monolithic AR displays that deliver high image quality and enhanced power efficiency. By providing microLED display modules on wafers, MICLEDI serves the semiconductor industry, contributing to the advancement of AR technology.

IVEX is a start-up originating from the University of Leuven, specializing in the development of tools and software designed for the testing and validation of advanced driver assistance systems (ADAS) and autonomous vehicles. The company comprises a diverse team and has established partnerships with global firms, notably Siemens, to enhance its growth in the high-tech sector. IVEX offers a cloud-based suite of testing and validation tools alongside an onboard real-time safety checker, which can function independently or in conjunction with other systems. Its solutions streamline the analysis of extensive driving data, enabling engineers to efficiently identify and categorize driving scenarios, create digital representations for simulation, and assess safety performance while minimizing computational resource usage. By focusing on safety and efficiency, IVEX aims to support the industry's need for reliable and effective validation of automated driving technologies.

Gorilla focuses on transforming the energy and utility industry through innovative energy data applications. The company addresses longstanding data challenges that hinder innovation by offering a robust architectural data foundation tailored specifically for energy companies. Its platform features a flexible data model and a stable environment, which includes reusable algorithms that facilitate a quicker digital transformation process. By automating data collection and providing tools for pricing, forecasting, and reporting, Gorilla empowers energy retailers to leverage data-driven technology, thereby enhancing their sales while mitigating risks. With offices in Antwerp, London, Austin, and Melbourne, Gorilla is positioned to support energy companies in maximizing their return on investment from data.

Minze Health is a Belgian healthtech startup founded in 2015 and headquartered in Antwerp. The company specializes in developing digital health solutions aimed at addressing urinary tract problems, particularly focusing on urologic, pelvic health, and continence care. Its platform facilitates the diagnostic and treatment processes, as well as remote patient monitoring for individuals suffering from lower urinary tract symptoms (LUTS). Minze Health's innovative solutions are utilized by hospitals, urology practices, and pelvic floor rehabilitation centers around the globe, enabling healthcare professionals to effectively diagnose and monitor their patients both in clinical settings and private practices.

eTheRNA immunotherapies NV specializes in the development of mRNA-based immunotherapies that harness the key role of dendritic cells in the immune system. The company focuses on treating melanoma, triple-negative breast cancer, and infectious diseases through its innovative TriMix technology, which enhances the immune response. Founded in 2013 and headquartered in Niel, Belgium, eTheRNA collaborates strategically with China Grand Pharmaceutical and Healthcare Holdings Limited to advance its research and development efforts. The company aims to lead in nucleic acid-based medicine, enabling partners to create new therapeutic options and improve patient outcomes.

CHILI Publish is a Belgium-based company that specializes in online editing software designed to transform original designs into Smart Templates. Founded in 2010 and headquartered in Erembodegem, the company aims to simplify and automate graphic production for businesses across various industries, including marketing, retail, cosmetics, and food and beverage. Its innovative software provides a comprehensive suite of templates and customizable features that facilitate the creation of on-brand visual communications for both print and packaging. By integrating with a wide range of third-party partners, CHILI Publish enables marketers, brands, and printers to utilize a self-service platform, enhancing efficiency in producing graphics for diverse purposes.

Sweepatic operates a cloud-based platform focused on External Attack Surface Management, aimed at enhancing cybersecurity for organizations. The platform continuously maps, monitors, and manages all internet-connected assets and associated risks, providing 24/7 observations and high-impact notifications through an intuitive dashboard. By leveraging this technology, Sweepatic helps organizations structure and reduce their external attack surface, thereby minimizing their vulnerability to cyber threats. Headquartered in Belgium, Sweepatic is committed to making its customers more cyber resilient by delivering actionable insights and easy-to-remediate findings.

reMYND NV is a biotechnology company based in Leuven, Belgium, focused on developing disease-modifying treatments for Alzheimer’s, Parkinson’s, diabetes, and other protein-misfolding disorders. The company is advancing several investigational compounds, including ReS19-T for Alzheimer’s and ReS39 for diabetes, as well as ReS3-T, which targets neuronal hyperactivity associated with Alzheimer’s and epilepsy. Additionally, reMYND operates a phenotypic screening platform aimed at discovering small molecule treatments that mitigate the toxicity of misfolded proteins such as Tau and Synuclein. The company also functions as a contract research organization (CRO), providing services that assess the in-vivo characteristics and effects of experimental therapies using proprietary mouse models. This CRO capability has enabled reMYND to support various pharmaceutical clients, including major companies in the United States, Europe, and Japan, by delivering critical proof-of-concept data for drugs in clinical development. Established in 2002, reMYND is committed to addressing the challenges posed by protein misfolding diseases through innovative research and development.

SettleMint offers a user-friendly platform that enables web2 engineers to build, deploy, and integrate applications on web3 infrastructure. The company provides a comprehensive suite of tools covering the entire web3 application development lifecycle. This includes node hosting as a service, customizable smart contract templates for over 50 use cases, and efficient on-chain data querying through Graph QL integration. Additionally, SettleMint supports decentralized data storage with IPFS node deployment, alongside centralized storage options. The platform features a fully automated and customizable user interface builder, ensuring scalability with easy resource management. With SOC2 certification and enterprise-grade capabilities, SettleMint simplifies the complexities of web3 development for businesses across Europe, the Middle East, Africa, India, and Asia-Pacific, with offices in key cities such as Belgium, Dubai, Delhi, Singapore, and Tokyo.

CHILI Publish is a Belgium-based company that specializes in online editing software designed to transform original designs into Smart Templates. Founded in 2010 and headquartered in Erembodegem, the company aims to simplify and automate graphic production for businesses across various industries, including marketing, retail, cosmetics, and food and beverage. Its innovative software provides a comprehensive suite of templates and customizable features that facilitate the creation of on-brand visual communications for both print and packaging. By integrating with a wide range of third-party partners, CHILI Publish enables marketers, brands, and printers to utilize a self-service platform, enhancing efficiency in producing graphics for diverse purposes.

eTheRNA immunotherapies NV specializes in the development of mRNA-based immunotherapies that harness the key role of dendritic cells in the immune system. The company focuses on treating melanoma, triple-negative breast cancer, and infectious diseases through its innovative TriMix technology, which enhances the immune response. Founded in 2013 and headquartered in Niel, Belgium, eTheRNA collaborates strategically with China Grand Pharmaceutical and Healthcare Holdings Limited to advance its research and development efforts. The company aims to lead in nucleic acid-based medicine, enabling partners to create new therapeutic options and improve patient outcomes.

QustomDot is a company based in Ghent, Belgium, specializing in the development and manufacturing of on-chip grade and cadmium-free quantum dots. These tiny semiconductor nanoparticles are designed to transform ultraviolet or blue light into pure colors, enhancing the image quality of various display technologies. QustomDot's products are applicable in LED/LCD televisions, smartphones, smartwatches, virtual and augmented reality goggles, and LED lighting solutions. The company not only produces quantum dots but also assists customers in integrating these advanced materials into their products, helping to improve color gamut and energy efficiency. Founded in 2020, QustomDot is focused on innovation in the field of advanced materials.

IVEX is a start-up originating from the University of Leuven, specializing in the development of tools and software designed for the testing and validation of advanced driver assistance systems (ADAS) and autonomous vehicles. The company comprises a diverse team and has established partnerships with global firms, notably Siemens, to enhance its growth in the high-tech sector. IVEX offers a cloud-based suite of testing and validation tools alongside an onboard real-time safety checker, which can function independently or in conjunction with other systems. Its solutions streamline the analysis of extensive driving data, enabling engineers to efficiently identify and categorize driving scenarios, create digital representations for simulation, and assess safety performance while minimizing computational resource usage. By focusing on safety and efficiency, IVEX aims to support the industry's need for reliable and effective validation of automated driving technologies.

MICLEDI Microdisplays BV specializes in designing and manufacturing micro light-emitting diode (microLED) display chips tailored for augmented reality (AR) glasses. Based in Leuven, Belgium, the company operates as a fabless developer, focusing on advanced technology that integrates III/V materials processing, 3D integration, and 300mm silicon-based processing. MICLEDI's proprietary application-specific integrated circuit (ASIC) enables the production of compact, monolithic AR displays that deliver high image quality and enhanced power efficiency. By providing microLED display modules on wafers, MICLEDI serves the semiconductor industry, contributing to the advancement of AR technology.

Augustine Therapeutics N.V., founded in 2019 and based in Gent, Belgium, focuses on developing innovative medicines for patients suffering from Charcot-Marie-Tooth disease and other neuromuscular disorders. The company is engaged in two drug discovery programs aimed at identifying new generations of selective HDAC6 inhibitors, which are designed to address axonopathies, including Charcot-Marie-Tooth disease. These novel compounds are intended to protect against nerve degeneration and facilitate the repair of peripheral myelin and axons. By advancing these therapeutic drugs, Augustine Therapeutics aims to enhance the quality of life for patients affected by these debilitating conditions.

Biotalys NV is an agricultural technology company based in Ghent, Belgium, that specializes in the research and development of biopesticides aimed at controlling pests and diseases affecting crops and harvested products. The company utilizes its proprietary Agrobody technology platform to create protein-based crop protection solutions that effectively bind to leaves, seeds, and fruits, enabling targeted delivery of active ingredients. This innovative approach combines the performance of traditional chemical pesticides with the safety profile of biological alternatives, making Biotalys' products suitable for both pre- and post-harvest applications. Founded in 2013, Biotalys is committed to providing sustainable and safe food protection solutions, positioning itself as a leader in the evolution of agricultural practices.

Unifly is a developer of unmanned traffic management software focused on the secure integration of drones into global airspace. Founded in 2015 by aerospace experts, the company emerged from a vision shared by air traffic controllers who recognized the need for effective management of the increasing number of drones. Unifly's award-winning platform connects authorities and drone operators, allowing for real-time monitoring and management of drone traffic, while providing pilots with essential information regarding the legal status of their flights. The platform is already utilized by national authorities in Germany, Denmark, Austria, and Belgium, and Unifly is also active in the United States and several projects worldwide, including Africa and Asia. By fostering collaboration with various stakeholders, Unifly aims to enhance airspace safety and facilitate the seamless integration of drones into everyday life, addressing critical concerns regarding safety and oversight in both recreational and commercial drone activities.

Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company focuses on developing internal drug discovery programs centered on G-protein coupled receptors (GPCRs), which are critical targets for therapeutic intervention. Utilizing its proprietary CONFO technology, Confo Therapeutics stabilizes active-state conformations of GPCRs, enabling researchers to access previously unreachable structural features. This innovation facilitates the discovery of novel agonists, addressing unmet medical needs and potentially leading to improved treatments in the medical field. The company aims to build a robust portfolio of drug discovery programs, leveraging its unique approach to enhance therapeutic options.

SupplyStack, based in Antwerp, Belgium, provides a real-time visibility solution for monitoring transport orders, enabling effective collaboration and automating various logistical processes. The company offers a comprehensive platform that integrates a visibility solution with a transport management system, allowing users to track and manage logistics efficiently. SupplyStack serves a diverse range of industries, including automotive, industrial manufacturing, FMCG, chemicals, wholesale and distribution, pharmaceuticals, and food and beverage. Its software facilitates real-time monitoring and planning of transportation flows, helping logistics service providers and shippers enhance operational efficiency and reduce costs while improving overall service quality.

reMYND NV is a biotechnology company based in Leuven, Belgium, focused on developing disease-modifying treatments for Alzheimer’s, Parkinson’s, diabetes, and other protein-misfolding disorders. The company is advancing several investigational compounds, including ReS19-T for Alzheimer’s and ReS39 for diabetes, as well as ReS3-T, which targets neuronal hyperactivity associated with Alzheimer’s and epilepsy. Additionally, reMYND operates a phenotypic screening platform aimed at discovering small molecule treatments that mitigate the toxicity of misfolded proteins such as Tau and Synuclein. The company also functions as a contract research organization (CRO), providing services that assess the in-vivo characteristics and effects of experimental therapies using proprietary mouse models. This CRO capability has enabled reMYND to support various pharmaceutical clients, including major companies in the United States, Europe, and Japan, by delivering critical proof-of-concept data for drugs in clinical development. Established in 2002, reMYND is committed to addressing the challenges posed by protein misfolding diseases through innovative research and development.

Teamleader, based in Belgium, is a software company that provides a comprehensive platform for project management and invoicing, aimed at helping entrepreneurs streamline their business operations. With over 7,000 paying customers, the company has experienced significant growth and is poised for further expansion. Teamleader's user-friendly interface, competitive pricing, and extensive integrations make it an appealing choice for businesses looking to manage their sales, project management, calendar, time tracking, invoicing, and ticketing in one place. By simplifying these essential functions, Teamleader enables clients to save time and focus on increasing their revenue.

Unifiedpost Group is a Belgian company that specializes in providing a cloud-based platform for administrative and financial services. Founded in 2001 and headquartered in La Hulpe, it facilitates digital connections between businesses, suppliers, and customers across various sectors, including corporate, government, agriculture, and construction. The company offers a range of solutions, including document processing, identity verification, payment automation, and procurement services, aimed at simplifying and enhancing business operations. Its invoicing solutions help organizations transition to electronic invoicing while ensuring compliance with local tax regulations. Additionally, Unifiedpost Group provides flexible invoice financing options to help small and medium-sized enterprises access working capital when needed. Overall, the company's platform is designed to streamline financial transactions and improve operational efficiency for its clients.

ONTOFORCE is a company that specializes in enhancing research and drug development within the life sciences sector by enabling organizations to uncover valuable insights from disparate data sources. Its primary product, DISQOVER, is a knowledge discovery platform built on semantic technology and ontology-based structures. This platform integrates an organization’s internal data with licensed and public data, facilitating efficient exploration and analysis. DISQOVER is user-friendly and customizable, catering to a diverse audience that includes scientific researchers, bioinformaticians, and data scientists. With over 10,000 global users, ONTOFORCE's solutions are adopted by many prominent pharmaceutical and biotechnology firms. The company is headquartered in Ghent, Belgium, and maintains a secondary office in Cambridge, Massachusetts.

Aelin Therapeutics is a Belgian biotherapeutics company established in 2017 and headquartered in Heverlee. It specializes in developing innovative antibiotics and therapeutics through its proprietary Pept-in technology, which utilizes protein aggregation to achieve functional knockdown of target proteins. This platform is designed to address challenging medical conditions, including infections caused by Methicillin-resistant Staphylococcus aureus (MRSA) and other undruggable targets in humans. The company was founded by VIB in collaboration with partner universities, including KU Leuven, VUB, and UGent, and is backed by extensive preclinical proof-of-concept data. Aelin Therapeutics' approach allows for the rational design of novel biotherapeutics, distinguishing itself from traditional therapeutic modalities by targeting intracellular spaces typically inaccessible to small molecules or antibodies. The technology's versatility extends beyond human applications, demonstrating efficacy against bacteria, cancer cells, fungi, viruses, and even plant cells.

Laminaria, founded in 2011 and based in Ostend, Belgium, specializes in manufacturing wave energy converter equipment. The company is at the forefront of developing technology designed to harness renewable wave energy, using a system that converts tilting and translating motions into power through mooring ropes connected to generators. Laminaria leads the LAMWEC project, a consortium of ocean energy experts that includes organizations such as EMEC, Innosea, Ghent University, and TTI Testing. Through its innovative technology, Laminaria aims to significantly impact the renewable energy landscape by advancing the effectiveness and efficiency of wave energy conversion.

Biotalys NV is an agricultural technology company based in Ghent, Belgium, that specializes in the research and development of biopesticides aimed at controlling pests and diseases affecting crops and harvested products. The company utilizes its proprietary Agrobody technology platform to create protein-based crop protection solutions that effectively bind to leaves, seeds, and fruits, enabling targeted delivery of active ingredients. This innovative approach combines the performance of traditional chemical pesticides with the safety profile of biological alternatives, making Biotalys' products suitable for both pre- and post-harvest applications. Founded in 2013, Biotalys is committed to providing sustainable and safe food protection solutions, positioning itself as a leader in the evolution of agricultural practices.

VIRTEO NV, founded in 2013 and based in Mechelen, Belgium, operates a SaaS platform designed for the recovery of unpaid invoices. The platform addresses both internal dunning and external debt collection processes, catering to a diverse clientele that includes corporations, small and medium-sized enterprises, public institutions, court bailiffs, and lawyers. By facilitating direct collaboration between credit managers and external partners such as lawyers and recovery agencies, VIRTEO enhances efficiency, transparency, and compliance in debt collection. The company aims to reconcile the often negative perception of the debt collection industry with socially responsible practices, enabling creditors to recover debts while adhering to ethical standards. Through its platform, VIRTEO empowers customers to monitor, control, and enforce their corporate social responsibility policies, ultimately improving recovery outcomes and reducing costs.

ONTOFORCE is a company that specializes in enhancing research and drug development within the life sciences sector by enabling organizations to uncover valuable insights from disparate data sources. Its primary product, DISQOVER, is a knowledge discovery platform built on semantic technology and ontology-based structures. This platform integrates an organization’s internal data with licensed and public data, facilitating efficient exploration and analysis. DISQOVER is user-friendly and customizable, catering to a diverse audience that includes scientific researchers, bioinformaticians, and data scientists. With over 10,000 global users, ONTOFORCE's solutions are adopted by many prominent pharmaceutical and biotechnology firms. The company is headquartered in Ghent, Belgium, and maintains a secondary office in Cambridge, Massachusetts.

eTheRNA immunotherapies NV specializes in the development of mRNA-based immunotherapies that harness the key role of dendritic cells in the immune system. The company focuses on treating melanoma, triple-negative breast cancer, and infectious diseases through its innovative TriMix technology, which enhances the immune response. Founded in 2013 and headquartered in Niel, Belgium, eTheRNA collaborates strategically with China Grand Pharmaceutical and Healthcare Holdings Limited to advance its research and development efforts. The company aims to lead in nucleic acid-based medicine, enabling partners to create new therapeutic options and improve patient outcomes.

Unifly is a developer of unmanned traffic management software focused on the secure integration of drones into global airspace. Founded in 2015 by aerospace experts, the company emerged from a vision shared by air traffic controllers who recognized the need for effective management of the increasing number of drones. Unifly's award-winning platform connects authorities and drone operators, allowing for real-time monitoring and management of drone traffic, while providing pilots with essential information regarding the legal status of their flights. The platform is already utilized by national authorities in Germany, Denmark, Austria, and Belgium, and Unifly is also active in the United States and several projects worldwide, including Africa and Asia. By fostering collaboration with various stakeholders, Unifly aims to enhance airspace safety and facilitate the seamless integration of drones into everyday life, addressing critical concerns regarding safety and oversight in both recreational and commercial drone activities.

neoScores is an innovative company based in Kontich, Belgium, that specializes in providing an online platform for purchasing and playing digital sheet music. Established in 2013 by three professional musicians—Bart Van der Roost, Bob Hamblok, and Jonas Coomans—the company aims to transform the way musicians access and utilize sheet music. The platform, known as Gustaf, is compatible across various operating systems and devices, enabling users to securely buy scores and share notes with fellow musicians from anywhere. With a focus on high-quality, flexible, and aesthetically pleasing digital scores, neoScores strives to enhance the musical experience for users, allowing them to engage with music seamlessly via smartphones, tablets, or computers.

Trod Medical S.A. is a medical device manufacturer founded in 2006, with headquarters in Leuven, Belgium, and the Tampa Bay area, USA. The company specializes in innovative ablation technologies, particularly in developing radiofrequency (RF) ablation devices. One of its key products, the EncageTM, is a percutaneous RF device designed to precisely ablate soft tissues, minimizing collateral damage during procedures. This technology is particularly significant in the treatment of prostate cancer, a prevalent condition with approximately 240,000 new cases diagnosed annually in the United States. Traditional treatments often lead to severe side effects, such as erectile dysfunction and urinary incontinence, highlighting the importance of Trod Medical's advancements. The company's devices enable healthcare providers to perform endoscopic surgeries with predictable ablation volumes and reduced tissue damage, aiming to improve patient outcomes in a critical area of medical care.

ONTOFORCE is a company that specializes in enhancing research and drug development within the life sciences sector by enabling organizations to uncover valuable insights from disparate data sources. Its primary product, DISQOVER, is a knowledge discovery platform built on semantic technology and ontology-based structures. This platform integrates an organization’s internal data with licensed and public data, facilitating efficient exploration and analysis. DISQOVER is user-friendly and customizable, catering to a diverse audience that includes scientific researchers, bioinformaticians, and data scientists. With over 10,000 global users, ONTOFORCE's solutions are adopted by many prominent pharmaceutical and biotechnology firms. The company is headquartered in Ghent, Belgium, and maintains a secondary office in Cambridge, Massachusetts.

Biotalys NV is an agricultural technology company based in Ghent, Belgium, that specializes in the research and development of biopesticides aimed at controlling pests and diseases affecting crops and harvested products. The company utilizes its proprietary Agrobody technology platform to create protein-based crop protection solutions that effectively bind to leaves, seeds, and fruits, enabling targeted delivery of active ingredients. This innovative approach combines the performance of traditional chemical pesticides with the safety profile of biological alternatives, making Biotalys' products suitable for both pre- and post-harvest applications. Founded in 2013, Biotalys is committed to providing sustainable and safe food protection solutions, positioning itself as a leader in the evolution of agricultural practices.

Caliopa NV is a company based in Zwijnaarde, Belgium, that specializes in the development and marketing of silicon photonics-based optical transceivers for the data and telecommunications markets. Established in 2010, Caliopa emerged as a spin-off from the Photonics Research Group of Ghent University and imec, leveraging advanced research and technological expertise to offer innovative solutions in optical communication.

iNEWiT is an engineering company based in Mechelen, Belgium, founded in 2005. The company specializes in identifying, designing, and creating applications and devices for the mobile market. It develops mobile video communication applications and offers a range of wireless communication technologies, including GPRS/EDGE, 3G, HSDPA/HSUPA, WiFi, WiMAX, and satellite networks. iNEWiT's products utilize patent-pending technology to transmit data, video, and sound across various wireless and wired environments and platforms. Additionally, the company provides plug-and-play products tailored for the business-to-consumer markets.

Cinvolve specializes in seat occupation monitoring services designed to enhance audience engagement in the cinema industry. Utilizing advanced sensors embedded in theater seating, Cinvolve's system provides real-time detection of seat occupancy, allowing cinema owners to gain insights into audience behavior. This technology eliminates the need for costly traditional ticket control services, empowering cinema operators and studios to leverage audience feedback and ratings to optimize movie programming and scheduling. Founded in 2004 and headquartered in Izegem, Belgium, Cinvolve has established itself as a key player in the integration of digital solutions within the entertainment sector.

iNEWiT is an engineering company based in Mechelen, Belgium, founded in 2005. The company specializes in identifying, designing, and creating applications and devices for the mobile market. It develops mobile video communication applications and offers a range of wireless communication technologies, including GPRS/EDGE, 3G, HSDPA/HSUPA, WiFi, WiMAX, and satellite networks. iNEWiT's products utilize patent-pending technology to transmit data, video, and sound across various wireless and wired environments and platforms. Additionally, the company provides plug-and-play products tailored for the business-to-consumer markets.